Zevra Therapeutics
ZVRA
ZVRA
108 hedge funds and large institutions have $201M invested in Zevra Therapeutics in 2024 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 38 increasing their positions, 19 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
16.7% more ownership
Funds ownership: 38.33% → 55.04% (+17%)
16% more funds holding
Funds holding: 93 → 108 (+15)
Holders
108
Holding in Top 10
3
Calls
$6.94M
Puts
$2.1M
Top Buyers
| 1 | +$20.1M | |
| 2 | +$16M | |
| 3 | +$6.83M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$6.4M |
| 5 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$4.86M |
Top Sellers
| 1 | -$890K | |
| 2 | -$887K | |
| 3 | -$738K | |
| 4 |
Renaissance Technologies
New York
|
-$553K |
| 5 |
BGIM
Brandywine Global Investment Management
Philadelphia,
Pennsylvania
|
-$526K |